Fumiya Shibagaki
Fumiya Shibagaki publishes mostly in Pharmacology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience, on topics such as Apelin-related biomedical research, Lipid metabolism and disorders and Cardiovascular, Neuropeptides, and Oxidative Stress Research.
- World rank
- #5,545,058 of 7,710,434 ranked researchers
- Rank in Japan
- #190,489 of 383,136
- Works
- 19
- Citations
- 198
- Citations per work
- 10.4
What does Fumiya Shibagaki research?
Fumiya Shibagaki's work is mostly in Medicine (53%), Neuroscience (15%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1053.2%
- Medicine1053.2%
- Everything else631.9%
- Life Sciences314.9%
- Neuroscience314.9%
- 1Pharmacology21% of their works
- 2Cardiology and Cardiovascular Medicine13% of their works
- 3Cellular and Molecular Neuroscience11% of their works
- 4Surgery11% of their works
- 5Oncology8% of their works
- 6Biological Psychiatry4% of their works
Research topics
- Apelin-related biomedical research
- Lipid metabolism and disorders
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
- Nuclear Receptors and Signaling
- Colorectal Cancer Treatments and Studies
- Tryptophan and brain disorders
- Neuroinflammation and Neurodegeneration Mechanisms
- Military Technology and Strategies
Which keywords describe Fumiya Shibagaki's research?
The keywords of their largest research topics: Hypertension, Atherosclerosis, Apelin, APJ Receptor, ANGPTL3, Lipoprotein Lipase, Neurodegeneration and Cardiovascular Disease.
- Synaptic Pruning
- Depression
- Air Force
- Cetuximab
- Neuroinflammation
- Microglia
- Cardiovascular Disease
- Lipoprotein Lipase
- Apelin
- Atherosclerosis
- Hypertension
- APJ Receptor
- ANGPTL3
- Neurodegeneration
- Urotensin II
- NR4A2
- Nurr1
- KRAS Mutations
- Astrocytes
- Modernization
- Tryptophan Metabolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Hypertension152 topics
- Atherosclerosis112 topics
- APJ Receptor101 topic
- Apelin101 topic
- ANGPTL361 topic
- Lipoprotein Lipase61 topic
- Neurodegeneration62 topics
- Cardiovascular Disease51 topic
- Urotensin II51 topic
- Microglia42 topics
- NR4A241 topic
- Neuroinflammation42 topics
- Nurr141 topic
- Cetuximab31 topic
- KRAS Mutations31 topic
- Air Force21 topic
- Astrocytes21 topic
- Depression21 topic
- Modernization21 topic
- Synaptic Pruning21 topic
- Tryptophan Metabolism21 topic
Where does Fumiya Shibagaki work?
Fumiya Shibagaki's main affiliation in the publication record is Setsunan University, Japan.
How many publications and citations does Fumiya Shibagaki have?
OpenAlex counts 19 works and 198 citations for Fumiya Shibagaki, an h-index of 6, ranking #5,545,058 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Fumiya Shibagaki. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.